These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35795468)
1. CSF3R T618I mutant myelodysplastic/myeloproliferative neoplasm in the elderly: An age-related disease with unfavorable prognosis. Zhang X; Ghiuzeli C; Jou E; Hsu P; Kolitz J; Brody JP Leuk Res Rep; 2022; 17():100334. PubMed ID: 35795468 [TBL] [Abstract][Full Text] [Related]
2. Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies. Kim SY; Song IC; Kim J; Kwon GC Ann Diagn Pathol; 2024 Aug; 71():152317. PubMed ID: 38642470 [TBL] [Abstract][Full Text] [Related]
3. Kwon A; Ibrahim I; Le T; Jaso JM; Weinberg O; Fuda F; Chen W Leuk Res Rep; 2022; 17():100323. PubMed ID: 35586707 [TBL] [Abstract][Full Text] [Related]
4. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature. Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413 [TBL] [Abstract][Full Text] [Related]
6. Myeloid Disease with the CSF3R T618I Mutation after CLL. Couto ME; Bizarro S; Sousa D; Domingues N; Oliveira I; Martins G; Teixeira MR; Mariz M Case Rep Hematol; 2020; 2020():6670965. PubMed ID: 33414971 [TBL] [Abstract][Full Text] [Related]
7. Coexisting of bone marrow fibrosis, dysplasia and an X chromosomal abnormality in chronic neutrophilic leukemia with CSF3R mutation: a case report and literature review. Wu XB; Wu WW; Zhou Y; Wang X; Li J; Yu Y BMC Cancer; 2018 Mar; 18(1):343. PubMed ID: 29587671 [TBL] [Abstract][Full Text] [Related]
8. [Emergence of mutation in the colony-stimulating factor 3 receptor gene during follow-up of unclassifiable myeloproliferative neoplasm]. Harada S; Okada K; Yokoyama S; Hidaka D; Hayase E; Onozawa M; Goto H; Hashimoto D; Kahata K; Endo T; Teshima T Rinsho Ketsueki; 2021; 62(11):1609-1614. PubMed ID: 34866084 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia. Ouyang Y; Qiao C; Chen Y; Zhang SJ Oncotarget; 2017 Mar; 8(13):20834-20841. PubMed ID: 28209919 [TBL] [Abstract][Full Text] [Related]
10. The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I. Maxson JE; Luty SB; MacManiman JD; Paik JC; Gotlib J; Greenberg P; Bahamadi S; Savage SL; Abel ML; Eide CA; Loriaux MM; Stevens EA; Tyner JW Clin Cancer Res; 2016 Feb; 22(3):757-64. PubMed ID: 26475333 [TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing reveals unique combination of mutations in cis of CSF3R in atypical chronic myeloid leukemia. Yun JW; Yoon J; Jung CW; Lee KO; Kim JW; Kim SH; Kim HJ J Clin Lab Anal; 2020 Feb; 34(2):e23064. PubMed ID: 31692115 [TBL] [Abstract][Full Text] [Related]
12. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Wang SA; Hasserjian RP; Fox PS; Rogers HJ; Geyer JT; Chabot-Richards D; Weinzierl E; Hatem J; Jaso J; Kanagal-Shamanna R; Stingo FC; Patel KP; Mehrotra M; Bueso-Ramos C; Young KH; Dinardo CD; Verstovsek S; Tiu RV; Bagg A; Hsi ED; Arber DA; Foucar K; Luthra R; Orazi A Blood; 2014 Apr; 123(17):2645-51. PubMed ID: 24627528 [TBL] [Abstract][Full Text] [Related]
13. [Impact of Li RQ; Wen XL; Zhang XL; Dong CX; Wang MF; Liu XX; Huang YJ; Tan YH; Chang JM; Zhang RJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):628-632. PubMed ID: 37356918 [TBL] [Abstract][Full Text] [Related]
14. Germline Bochicchio MT; Micucci G; Asioli S; Ghetti M; Simonetti G; Lucchesi A Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003211 [TBL] [Abstract][Full Text] [Related]
16. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343 [TBL] [Abstract][Full Text] [Related]
17. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis. Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910 [TBL] [Abstract][Full Text] [Related]
18. CSF3R and CALR mutations in paediatric myeloid disorders and the association of CSF3R mutations with translocations, including t(8; 21). Sano H; Ohki K; Park MJ; Shiba N; Hara Y; Sotomatsu M; Tomizawa D; Taga T; Kiyokawa N; Tawa A; Horibe K; Adachi S; Hayashi Y Br J Haematol; 2015 Aug; 170(3):391-7. PubMed ID: 25858548 [TBL] [Abstract][Full Text] [Related]
19. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Qian Y; Chen Y; Li X Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276 [TBL] [Abstract][Full Text] [Related]
20. Clonal evolution in a chronic neutrophilic leukemia patient. Zhang QG; Wang J; Gong WY; Jing QC Hematology; 2019 Dec; 24(1):455-458. PubMed ID: 31076019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]